- Home
- PSNL vs GUG Comparison
PSNL vs GUG Comparison
Compare PSNL & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- GUG
- Stock Information
- Founded
- PSNL 2011
- GUG 2021
- Country
- PSNL United States
- GUG United States
- Employees
- PSNL N/A
- GUG N/A
- Industry
- PSNL Medical Specialities
- GUG Trusts Except Educational Religious and Charitable
- Sector
- PSNL Health Care
- GUG Finance
- Exchange
- PSNL Nasdaq
- GUG Nasdaq
- Market Cap
- PSNL 562.6M
- GUG 470.0M
- IPO Year
- PSNL 2019
- GUG N/A
- Fundamental
- Price
- PSNL $6.45
- GUG $15.35
- Analyst Decision
- PSNL Strong Buy
- GUG
- Analyst Count
- PSNL 5
- GUG 0
- Target Price
- PSNL $8.00
- GUG N/A
- AVG Volume (30 Days)
- PSNL 1.7M
- GUG 108.9K
- Earning Date
- PSNL 08-06-2025
- GUG 01-01-0001
- Dividend Yield
- PSNL N/A
- GUG 9.67%
- EPS Growth
- PSNL N/A
- GUG N/A
- EPS
- PSNL N/A
- GUG N/A
- Revenue
- PSNL $85,694,000.00
- GUG N/A
- Revenue This Year
- PSNL $0.45
- GUG N/A
- Revenue Next Year
- PSNL $25.75
- GUG N/A
- P/E Ratio
- PSNL N/A
- GUG N/A
- Revenue Growth
- PSNL 15.57
- GUG N/A
- 52 Week Low
- PSNL $2.61
- GUG $12.71
- 52 Week High
- PSNL $7.79
- GUG $15.06
- Technical
- Relative Strength Index (RSI)
- PSNL 48.39
- GUG 45.59
- Support Level
- PSNL $6.12
- GUG $15.17
- Resistance Level
- PSNL $6.67
- GUG $15.53
- Average True Range (ATR)
- PSNL 0.48
- GUG 0.18
- MACD
- PSNL -0.14
- GUG -0.04
- Stochastic Oscillator
- PSNL 5.33
- GUG 20.00
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.